Dr. Johnson on Racial Disparities in Outcomes Across Multiple Tumor Types

Video

Anita Johnson, MD, FACS, discusses racial disparities in outcomes across multiple tumor types.

Anita Johnson, MD, FACS, a breast surgeon, and the breast cancer program director at Cancer Treatment Centers of America, discusses racial disparities in outcomes across multiple tumor types.

A study that was conducted by the National Cancer Institute reviewed disparities across several tumor types in oncology, according to Johnson. When death rates are compared across cancer types, the mortality rates of African American patients are significantly higher vs Caucasian patients. Additionally, when examining the incidence of breast cancer by race, rates are equal between Black and White women. However, mortality rates are significantly higher for African American women stage for stage, Johnson says.

While death rates are declining in prostate cancer as a whole, Black men continue to be twice as likely to die from the disease compared with White men. Moreover, in cervical cancer, Black and Hispanic women have higher incidence rates, although Black women are notably dying at a higher rate, Johnson concludes.

Related Videos
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD
Video 5 - "AE Management with CDK4/6 Inhibitors: Strategies for Treatment Continuity and Optimal Patient Outcomes"
Jeffrey P. Townsend, PhD
Rohan Garje, MD
Rita Nanda, MD
Siddartha Yadav, MD, FACP
Nan Chen, MD
Robert Dreicer, MD, director, Solid Tumor Oncology, Division of Hematology/Oncology, professor of Medicine and Urology, deputy director, University of Virginia Cancer Center
Carmen Guerra, MD, MSCE, FACP